Definitive Contract 75F40124C00078

This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the FDA. Aneon Brillient, a minority-owned small disadvantaged business, has previously secured other FDA contracts, including support for the Oncology Center of Excellence, the Office of Global Policy and Strategy, and medical product development activities.